S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Bellerophon Therapeutics (BLPH) News Today

$0.06
0.00 (0.00%)
(As of 04/18/2024 ET)
SourceHeadline
MarketBeat logoStockNews.com Begins Coverage on Bellerophon Therapeutics (NASDAQ:BLPH)
americanbankingnews.com - April 14 at 2:18 AM
uk.finance.yahoo.com logoBellerophon Therapeutics, Inc. (BLPH)
uk.finance.yahoo.com - February 25 at 7:44 AM
investing.com logoBellerophon Therapeutics Inc (BLPH)
investing.com - February 15 at 2:18 AM
msn.com logoBellerophon Offers Series A Stock in Private Sale
msn.com - January 31 at 8:34 PM
benzinga.com logoHilco Streambank Seeks Offers to Acquire Patent Portfolio and Material Inventory of Biotherapeutics Company Bellerophon
benzinga.com - November 28 at 2:49 PM
morningstar.com logoBellerophon Therapeutics Inc BLPH
morningstar.com - November 2 at 3:08 PM
finance.yahoo.com logoBLPH - Bellerophon Therapeutics, Inc.
finance.yahoo.com - August 8 at 3:59 PM
msn.com logoWhat's Happening With Bellerophon Therapeutics Stock Today?
msn.com - July 25 at 11:09 PM
investorplace.com logoWhy Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?
investorplace.com - July 25 at 10:03 AM
msn.com logoBellerophon Therapeutics (BLPH) Price Target Decreased by 92.23% to 2.04
msn.com - July 6 at 12:36 PM
markets.businessinsider.com logoThe Latest Analyst Ratings for Bellerophon Therapeutics
markets.businessinsider.com - June 6 at 5:34 PM
finance.yahoo.com logoIs Bellerophon Therapeutics (BLPH) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - June 6 at 12:34 PM
msn.com logoLaidlaw & Co. Downgrades Bellerophon Therapeutics (BLPH)
msn.com - June 6 at 7:33 AM
msn.com logoHC Wainwright & Co. Maintains Bellerophon Therapeutics (BLPH) Buy Recommendation
msn.com - June 6 at 7:33 AM
msn.com logoBellerophon Therapeutics Stock Nosedive: Here's Why
msn.com - June 5 at 9:33 PM
msn.com logoWhy Is Bellerophon Therapeutics (BLPH) Stock Down 79% Today?
msn.com - June 5 at 10:40 AM
finance.yahoo.com logoBellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease
finance.yahoo.com - June 5 at 10:40 AM
marketbeat.com logo
marketbeat.com - June 5 at 6:57 AM
msn.com logoLucy Scientific, Bioventus top healthcare gainers; Enveric, Elevation among losers
msn.com - May 19 at 11:00 AM
marketbeat.com logoHC Wainwright Brokers Increase Earnings Estimates for Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)
marketbeat.com - May 19 at 7:49 AM
finance.yahoo.com logoBellerophon Therapeutics (NASDAQ:BLPH) delivers shareholders fantastic 978% return over 1 year, surging 18% in the last week alone
finance.yahoo.com - May 17 at 10:28 AM
finanznachrichten.de logoBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results
finanznachrichten.de - May 16 at 9:38 AM
finance.yahoo.com logoBellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 15 at 7:59 PM
finance.yahoo.com logoBellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
finance.yahoo.com - May 11 at 8:41 AM
finance.yahoo.com logoBellerophon Therapeutics (BLPH) Outpaces Stock Market Gains: What You Should Know
finance.yahoo.com - April 28 at 9:31 PM
finance.yahoo.com logoBellerophon (BLPH) to Report Q1 Earnings: What's in the Cards?
finance.yahoo.com - April 24 at 5:13 PM
finance.yahoo.com logoBellerophon Therapeutics (BLPH) Dips More Than Broader Markets: What You Should Know
finance.yahoo.com - April 19 at 8:56 PM
marketbeat.com logoBellerophon Therapeutics, Inc. (NASDAQ:BLPH) Short Interest Down 40.8% in March
marketbeat.com - April 16 at 4:56 AM
msn.com logoBellerophon Therapeutics (BLPH) Stock Sinks As Market Gains: What You Should Know
msn.com - April 13 at 7:45 PM
msn.com logoHC Wainwright & Co. Reiterates Bellerophon Therapeutics (BLPH) Buy Recommendation
msn.com - April 4 at 7:06 PM
markets.businessinsider.com logoH.C. Wainwright Reaffirms Their Buy Rating on Bellerophon (BLPH)
markets.businessinsider.com - April 4 at 8:54 AM
finance.yahoo.com logoWhen Will Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) Turn A Profit?
finance.yahoo.com - April 3 at 1:10 PM
seekingalpha.com logoBellerophon Therapeutics GAAP EPS of -$2.08 misses by $0.06
seekingalpha.com - April 2 at 10:07 AM
finanznachrichten.de logoBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results
finanznachrichten.de - March 31 at 5:29 PM
finance.yahoo.com logoBellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results
finance.yahoo.com - March 31 at 9:18 AM
finance.yahoo.com logoBellerophon Therapeutics (BLPH) Is a Great Choice for 'Trend' Investors, Here's Why
finance.yahoo.com - March 28 at 2:00 PM
finance.yahoo.com logoHere's Why Momentum in Bellerophon Therapeutics (BLPH) Should Keep going
finance.yahoo.com - March 10 at 7:29 PM
baystreet.ca logoBellerophon to Buy Rival Firm’s Shares
baystreet.ca - March 6 at 11:07 AM
markets.businessinsider.com logoBellerophon Therapeutics Surges 30% On Share Subscription Agreement With An Institutional Investor
markets.businessinsider.com - March 6 at 11:07 AM
finance.yahoo.com logoBellerophon Therapeutics Announces $5 Million Registered Direct Offering
finance.yahoo.com - March 6 at 11:07 AM
finance.yahoo.com logoBellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Disease
finance.yahoo.com - February 9 at 9:51 AM
finance.yahoo.com logoBellerophon Therapeutics Announces Completion of Enrollment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
finance.yahoo.com - January 18 at 5:43 PM
benzinga.com logoHow Is The Market Feeling About Bellerophon Therapeutics?
benzinga.com - January 6 at 2:45 PM
benzinga.com logoShort Volatility Alert: Bellerophon Therapeutics
benzinga.com - January 6 at 9:43 AM
finance.yahoo.com logoCompanies Like Bellerophon Therapeutics (NASDAQ:BLPH) Could Be Quite Risky
finance.yahoo.com - January 6 at 9:43 AM
finance.yahoo.com logoBellerophon Therapeutics Shares Gained Over 200% Today
finance.yahoo.com - January 5 at 1:01 PM
finanznachrichten.de logoBellerophon Therapeutics, Inc.: Bellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Results
finanznachrichten.de - November 14 at 1:37 PM
finance.yahoo.com logoBellerophon Provides Clinical Program Update and Reports Third Quarter 2022 Financial Results
finance.yahoo.com - November 14 at 8:36 AM
finance.yahoo.com logoBellerophon (BLPH) Receives FDA Acceptance to Reduce Study Size
finance.yahoo.com - September 28 at 5:15 PM
finance.yahoo.com logoWhy Are Bellerophon Shares Jumping Today?
finance.yahoo.com - September 27 at 4:12 PM
Get Bellerophon Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLPH and its competitors with MarketBeat's FREE daily newsletter.

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

BLPH Media Mentions By Week

BLPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLPH
News Sentiment

0.69

0.49

Average
Medical
News Sentiment

BLPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLPH Articles
This Week

2

0

BLPH Articles
Average Week

Get Bellerophon Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLPH and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BLPH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners